SU14813 double bond Z
CAS : 452105-23-6
Ref. 3D-CTA10523
| 5mg | Arrêté | ||
| 10mg | Arrêté | ||
| 25mg | Arrêté | ||
| 50mg | Arrêté | ||
| 100mg | Arrêté |
Informations sur le produit
Nom :
SU14813 double bond Z
Description :
SU14813 is a potent inhibitor of angiogenesis and tumor growth. It has been shown to inhibit the growth of both solid tumors and hematopoietic cells, such as cancer stem cells. This drug also inhibits the production of vascular endothelial growth factor (VEGF), which is a key regulator of neovascularization. SU14813 can be used in combination with other drugs that are known to have antiangiogenic effects, such as radiation therapy or anti-VEGF agents. The most common side effect observed in clinical trials was ocular irritation and eye redness, although this may be due to its use in eye disorders.
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
442.48 g/mol
Formule :
C23H27FN4O4
Degré de pureté :
Min. 95%
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
